Despite the robust induction of CTA gene expression in breast cancer PDX tumors and cell lines upon DNMTi treatment, our investigation revealed a marked heterogeneity at the single-cell level, even with effective DNMT enzyme depletion. The gene discussed is DNMT1; the disease is breast carcinoma.